Literature DB >> 4383394

The action of the antihistaminic agents antazoline and meclizine on experimental arrhythmias.

E Kabela, M A Mena, M Martinez-Lopez, R Mendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4383394

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN： 0001-5385            Impact factor:   1.718


× No keyword cloud information.
  3 in total

1.  Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter.

Authors:  R Mendez; E Kabela; G Pastelin; M Martínez-López; S Sánchez-Pérez
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

2.  Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

Authors:  Michal M Farkowski; Aleksander Maciag; Rafal Dabrowski; Mariusz Pytkowski; Ilona Kowalik; Hanna Szwed
Journal:  Trials       Date:  2012-09-11       Impact factor: 2.279

3.  Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study.

Authors:  Maciej T Wybraniec; Wojciech Wróbel; Katarzyna Wilkosz; Karolina Wrona; Karolina Bula; Katarzyna Mizia-Stec
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.